Introduction Artificial intelligence (AI) is increasingly pivotal in driving innovation and efficiency as the pharmaceutical industry evolves. From drug discovery to patient care, AI applications are reshaping how companies approach challenges and opportunities in healthcare. This article explores the diverse AI applications within pharmaceuticals, highlighting key impact areas, their effects…
Read More
The rise of open-source platforms, such as China’s DeepSeek AI, is poised to transform not just the Tech World but all businesses including pharma. With the power of collaboration and open-source artificial intelligence (AI), initiatives like DeepSeek AI can drive the creation of novel therapeutic targets and molecules. This new…
The untold story of Glenmark’s phenomenal success in building a brand, Telma, which has 16 brand extensions and a combined turnover of Rs 1036 crore. Glenmark’s Telma brand, which contains Telmisartan, has become well-known for treating hypertension and heart failure and preventing heart attacks and strokes. The HBR case study…
Competitor Analysis – Indian Pharma Market Jan 2025 This analysis breaks down the competitive landscape by focusing on Competitor Analysis – Indian Pharma Market (Jan 2025) Market Leaders (Strongest Competitors) These companies have the highest market share, strong brand portfolios, and consistent growth. 🏆 A. Abbott (4 brands in the…
Overall Market Performance (IPM)• The Indian Pharmaceutical Market (IPM) recorded a total value of ₹229,260.6 crore, with an overall growth of 7.6% for Dec’24.• Out of 26 regions, 12 states/regions grew faster than the IPM growth rate of 7.6%, while the rest grew equal to or slower. Regional Zone-Wise Performance1….
Growth Performance of Top 50 Companies in IPM (MAT Dec’24) The top 50 pharmaceutical companies in the Indian Pharmaceutical Market (IPM) have grown significantly in various zones (West, South, North, and East). The following key insights emerge:• The top 30 cities contributed 34% to IPM Sales for MAT Dec’24.• The…